ArticleInternational journal of chronic obstructive pulmonary disease2017

Cost-effectiveness analysis of umeclidinium/vilanterol for the management of patients with moderate to very severe COPD using an economic model.

Michele R Wilson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.